Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the appointment of Marino Garcia to the newly created role of Executive Vice President and Chief Strategy Officer, effective …
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX), NY-based drug company Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and NV-based pharma company …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the initiation of the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two …
In a research report released Thursday, Cantor analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) and slightly raised her price target to $8.50 …
In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP), but reduced his price …
In a research report released today, Cantor analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with an $8 price target, following the …
Cantor analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) but reduced her price target to $8 (from $11), which represents a potential …
In a research report released Tuesday, analyst Irina Rivkind of Cantor assigned a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with an $11 price target, following the presentation of results …
In a research report sent to investors today, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with a $11 price target, as the …
In a research report released today, Roth Capital analyst Scott Henry maintained coverage with a Buy rating on Synergy Pharmaceuticals (SGYP), and a $8.50 price target, following the company’s second …
